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Neonatal deaths account for 40% of global under-five mortality and are ever
more important if we are to achieve the Millennium Development Goal 4 (MDG
4) on child survival. We applied a results framework to evaluate global and
national changes for neonatal mortality rates (NMR), healthy behaviours,
intervention coverage, health system change, and inputs including funding,
while considering contextual changes. The average annual rate of reduction of
NMR globally accelerated between 2000 and 2010 (2.1% per year) compared
with the 1990s, but was slower than the reduction in mortality of children aged
1–59 months (2.9% per year) and maternal mortality (4.2% per year). Regional
variation of NMR change ranged from 3.0% per year in developed countries to
1.5% per year in sub-Saharan Africa. Some countries have made remarkable
progress despite major challenges. Our statistical analysis identifies inter-country
predictors of NMR reduction including high baseline NMR, and changes in
income or fertility. Changes in intervention or package coverage did not appear
to be important predictors in any region, but coverage data are lacking for
several neonatal-specific interventions. Mortality due to neonatal infection
deaths, notably tetanus, decreased, and deaths from complications of preterm
birth are increasingly important. Official development assistance for maternal,
newborn and child health doubled from 2003 to 2008, yet by 2008 only 6% of
this aid mentioned newborns, and a mere 0.1% (US$4.56m) exclusively targeted
newborn care. The amount of newborn survival data and the evidence based
increased, as did recognition in donor funding. Over this decade, NMR reduction
seems more related to change in context, such as socio-economic factors, than to
increasing intervention coverage. High impact cost-effective interventions hold
great potential to save newborn lives especially in the highest burden countries.
Accelerating progress requires data-driven investments and addressing
context-specific implementation realities.
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KEY MESSAGES
 In 2010, 3.1 million newborns died in the first month of life, 17% fewer than in 2000. The annual rate of reduction of the
neonatal mortality rate (NMR) globally (2.1%) has accelerated since 2000, but remains slower than the rate of reduction
for maternal mortality (4.2%) and mortality amongst children aged 1–59 months (2.9%). Variation between regions and
countries is considerable and not previously analysed.
 There has been progress in reducing most causes of death since 2000, especially tetanus as well as neonatal infections
addressable through child health programmes - pneumonia and diarrhoea. Deaths due to preterm birth complications are
decreasing more slowly, and these are now the second leading cause of child deaths, requiring innovation for prevention
solutions and urgent scale up of care solutions.
 Our statistical analysis of inter-country NMR reduction suggests that in the last decade contextual factors, such as
changes in income and fertility, are associated with more rapid NMR reduction, with measureable coverage change of
newborn-related interventions contributing little. Lack of coverage data for some key interventions is a critical gap. In
Africa, NMR change has been so limited that statistical modelling was not helpful in identifying predictors.
 Official development assistance (ODA) for maternal, newborn and child health nearly doubled from 2003 to 2008, yet
even by 2008 only 6.1% of this funding mentioned newborn-related activities. Per live birth in 2009, this equates to
US$3.51 in ODA mentioning newborns or US$0.13 in ODA exclusively targeting newborns. Currently, government
funding is not systematically tracked for reproductive, maternal, newborn and child health.
 Over the last decade, and especially since 2005, there have been major advances in the evidence base for newborn
survival—particularly more data and greater frequency of burden of disease estimation—and in consensus for
implementation, as well as some increases in funding. In order to accelerate progress, greater emphasis is required on
scaling up care, especially in the highest burden countries, and addressing context-specific implementation challenges
regarding personnel, supplies and monitoring.
Introduction
Over the last decade newborn deaths have decreased by 17%,
yet in the year 2010, an estimated 3.1 million neonates
(0–28 days) died, mainly in low-income countries (UNICEF
et al. 2011). Newborn deaths were rarely mentioned in global
policy and programmes prior to the year 2000, but more
recently global organizations and country governments have
increased attention for newborn survival (G8 2009; Shiffman
2010).
Much of the focus on neonatal survival has been driven by
the Millennium Development Goal (MDG) 4 for child survival,
which targets a two-thirds reduction in under-five mortality
between 1990 and 2015. The proportion of under-five deaths
that occur in the first month of life has increased over the last
decade, and today is more than 40% (Oestergaard et al. 2011;
UNICEF et al. 2011). Hence, progress towards MDG 4 will be
increasingly determined by success in reducing newborn
deaths. The Lancet’s Newborn Survival Series in 2005 catalysed
increased attention and influenced global and national health
agendas (Lawn et al. 2006c), with new data on national
numbers and causes of newborn death (Lawn et al. 2005),
solutions and costs (Darmstadt et al. 2005), especially for
implementation in low-income countries (Knippenberg et al.
2005).
An analysis of the neonatal mortality rate (NMR) found that
while the rate of reduction is slower than for maternal and
under-five deaths, the pace has accelerated since 2000 (Hill
et al. 2012). However, huge variability between regions and
even between neighbouring countries exists (Oestergaard et al.
2011). Some countries, including those with low average
incomes and relatively few health workers, have made
remarkable progress in reducing neonatal deaths or in increas-
ing coverage particularly of skilled attendance, compared with
their neighbours. More analysis is now possible given recent
improvements in trend data for neonatal mortality and
cause-specific mortality estimates globally, regionally and
nationally (Black et al. 2010; Lozano et al. 2011; Oestergaard
et al. 2011; Liu et al. 2012).
To date, there has been no systematic multi-country
evaluation of the changes in newborn survival, or of the
processes and pathways that may influence scale up of
effective interventions. This paper, the first in a supplement
of seven papers, applies a results framework to examine
global and regional changes for newborn survival between
2000 and 2010 in terms of mortality, coverage and health
system indicators as well as national and donor funding,
using primarily quantitative data. The overall supplement of
seven papers, including five detailed country case studies,
examines neonatal mortality reduction from 2000 to 2010,
considering associated changes in coverage of care and
funding, as well as qualitative markers of health system
and policy change, in order to identify common pathways to
scale and potential accelerators and constraints (Box 1). What
has changed globally since 2000 and how has it manifested
in different regions, country contexts and health systems?
Has increased attention translated into programmatic action
and fewer deaths? Or is global progress in neonatal mortality
reduction simply due to socio-economic change or other
contextual factors? What may have influenced more rapid
policy and programmatic change? Such analyses and insights
will help inform priorities for accelerating progress for
newborn survival and also increase understanding of other
large-scale system change. They may also contribute to
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debates about mixed-method assessments of health system
change (Bennett et al. 2011).
Frameworks for integration of newborn care at scale
Highly cost-effective interventions exist to reduce neonatal
deaths (Darmstadt et al. 2005). However, there is no single
‘magic bullet’ intervention or ‘one size fits all’ programmatic
approach (Knippenberg et al. 2005). There are some interven-
tions that may be effectively delivered vertically, such as
tetanus immunization, but most high impact newborn care
interventions are intended to be integrated within packages
across the continuum of care from pregnancy, birth and the
postnatal period and through all levels of the health system
(Marsh et al. 2002; Lawn and Kerber 2006; Lawn et al. 2006b;
Kerber et al. 2007). Nine health service delivery packages that
impact newborn health exist in most health systems, and
involve links with reproductive, maternal and child health as
well as immunization, malaria, HIV/AIDS, nutrition and other
programmes (Figure 1) (Kerber et al. 2007). There is increasing
global consensus around these interventions, underscored by
the recent publication of essential maternal, newborn and child
health (MNCH) packages and interventions agreed to by
multiple organizations (PMNCH 2011). Implementation at
scale of evidence-based care would prevent around two-thirds
of newborn deaths (Darmstadt et al. 2008).
Local context is important when considering the potential
reach and performance of health systems for addressing MNCH.
In contexts with high NMR and weaker formal health systems,
there may be opportunities to strengthen entry points closer to
home, such as community preventive care packages of preg-
nancy and postnatal visits (WHO et al. 2009), and community
case management of neonatal sepsis (Bang et al. 1999), while
engaging in broader health facility and health system
strengthening. Effective care at birth to reduce neonatal
deaths, stillbirths and maternal deaths requires strengthening
human resource capacity, though there is scope to improve care
at birth even in settings with low rates of skilled attendance at
delivery (Lawn et al. 2009b). Scaling up of newborn survival
interventions involves interactions with many policies, pro-
grammes, cadres of worker and supply systems while consider-
ing local context and is therefore a useful example for
examining the process towards change at scale.
Box 1 A decade of change for newborn survival: supplement objectives and overview
Overall supplement objectives:
(1) Describe changes in national neonatal mortality and causes of neonatal deaths at global and regional level with more detail for
selected countries (goal level of the results framework).
(2) Evaluate factors that may have contributed to mortality change including coverage of key health interventions and also
considering contextual factors (strategic objective level).
(3) Undertake analysis of funding flows including government and out-of-pocket funding (from National Health Accounts)
and a novel multi-country analysis of official development assistance (ODA) delineating newborn-specific funding
where possible.
(4) For selected countries, through a consultation with national stakeholder and other experts, examine national policy and
programme changes and inputs to identify pivotal events that may have contributed to scale up of newborn care, using
comparable tools as follows (see Box 3):
– Policy and Programme Timeline
– Scale-up Readiness Benchmarks
– Geographic reach assessment
(5) Compile quantitative and qualitative data on changes across multiple countries and consider implications for reducing
neonatal mortality, and scaling up of coverage of care, identifying potential accelerators and constraints, to inform
future priorities for newborn care, and for use in public health more broadly.
Overview of the supplement:
The lead editorial highlights common themes and challenges, cross-cutting learning about the process of change, as well as
potential opportunities for saving newborn lives (Darmstadt et al. 2012).
This first paper applies the results framework to examine broad and mainly quantitative global and regional changes for
newborn survival between 2000 and 2010.
The second paper describes a novel methodology for measuring national readiness to implement newborn care interventions
at scale in the form of quantifiable benchmarks and presents results for nine countries (Moran et al. 2012).
Papers three through seven examine in detail the changes for newborn survival in selected countries, including Bangladesh,
Nepal, Pakistan, Malawi and Uganda (Khan et al. 2012; Mbonye et al. 2012; Pradhan et al. 2012; Rubayet et al. 2012; Zimba
et al. 2012). To avoid duplication, methods for the country case studies are detailed in this paper. Each country analysis is
structured around the same results framework, applying standard analyses and qualitative assessment tools, with critical
input from a wide team of country experts and stakeholders.
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Frameworks for evaluation of newborn survival
Conceptual frameworks for health can be used for problem
characterization, implementation or evaluation (Marsh et al.
2008; Ergo et al. 2011). Some frameworks focus on principles,
such as DFID’s four pillars (women’s empowerment, removal of
barriers preventing access, quality, and accountability) (DFID
2010). The International Health Partnership proposed a
common framework for evaluating MNCH programmes, and
stressed the importance of standardized process documentation,
as well as comparable designs for country-level evaluations
(Bryce et al. 2011).
Global public health experts are grappling with appropriate
evaluation designs to assess complex programmes especially
with concurrent changes in context (Bryce and Victora 2005).
Randomized trials are not always possible or appropriate but
are of particular value in evaluations which try to understand
the relationship between different interventions and outcomes
and to control for contextual factors (English et al. 2011).
Where randomized trials are not possible or feasible, data are
needed to capture changes in programme results and changes
in context over time (Victora et al. 2011).
Multi-country evaluations of MNCH packages using a stand-
ard evaluation framework and a rigorous design remain rare.
When these have been done, success has largely depended on
choosing the right interventions and delivery package, increasing
coverage of the selected interventions, and effective measure-
ment, especially in the context of rapid change. Two valuable
examples of evaluations of packages with curative and promo-
tive care are the Integrated Management of Childhood Illness
(IMCI) multi-country evaluation in five countries (Bangladesh,
Brazil, Peru, Tanzania and Uganda) (Bryce et al. 2005) and the
Accelerated Child Survival and Development (ACSD) pro-
gramme in three African countries (Benin, Ghana and Mali)
(Bryce et al. 2010). Both evaluations found that services did not
achieve desired coverage and quality and that child mortality did
not decrease compared with control groups. The ACSD evalu-
ation found increased coverage in preventive interventions
delivered by outreach and campaign strategies (e.g. immuniza-
tions and vitamin A supplementation), but it noted that these
were the lower impact interventions (Jones et al. 2003). Neither
the IMCI nor the ACSD evaluation included the highest impact
interventions to reduce neonatal deaths.
Figure 1 Integrated service delivery packages for maternal, newborn and child health
Source: Kerber et al. (2007). Note: First published in Disease Control Priorities in Developing Countries chapter (Lawn et al. 2006b), then revised with inputs
from consensus group for Women Deliver in 2008, and then specific adaption for Africa (Kinney et al. 2010). This figure has been updated here with
newborn health interventions from a review of essential interventions by PMNCH (PMNCH 2011) and Born Too Soon: The Global Action Report on
Preterm Birth (March of Dimes et al. 2012). Abbreviations used: ANC¼ antenatal care; CPAP¼ continuous positive airway pressure; HIV¼human
immunodeficiency virus; IPTi¼ intermittent preventive treatment in infants; IPTp¼ intermittent preventive treatment during pregnancy for malaria;
ORS¼ oral rehydration solution; PMTCT¼ prevention of mother-to-child transmission of HIV; pPROM¼ prelabor premature rupture of membranes;
STI¼ sexually transmitted infection; TOP¼ termination of pregnancy.
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Saving Newborn Lives programme and results framework
Most frameworks with the goal of improved health outcomes
focus on intervention coverage and have variable constructs
related to intermediate results and inputs (Marsh et al. 2008;
Victora et al. 2011). The conceptual framework used in this
supplement is consistent with the components in the
International Health Partnership framework (Bryce et al. 2011).
Save the Children’s Saving Newborn Lives (SNL) programme
adapted a standard logical framework in 2006 in order to guide
programming and evaluation of national newborn survival
programmes at scale. The main adaptations were an emphasis
on context, health system change and an explicit inclusion of
equity at the strategic objective level (Figure 2). The SNL results
framework considers the goal (saving newborn lives, measured by
reduced NMR) to be a result of the strategic objective of increased
equitable coverage of evidence-based newborn services and
healthy behaviours. Increased coverage is a result of programme
change at scale within the health system through the achievement
of short-term outcomes or intermediate results. These results include
improving availability and access of newborn care services
through: developing human resource capacity and availability of
essential equipment and medicines; ensuring quality of care;
increasing demand for services by families and communities; and,
achieving a supportive policy environment including availability
of adequate financial resources. The processes (inputs and
influence) listed interact to promote systems change: evidence
generation, advocacy and use of data for planning,
consensus-building mechanisms and partnerships. In addition,
the socio-political, economic, environmental, biologic and legal
context affects all levels of the change.
Objectives
This first paper in the supplement on a decade of change for
newborn survival (Box 1) applies the SNL results framework to
a multi-county evaluation examining global and regional
changes for newborn survival between 2000 and 2010 in
terms of variation in neonatal mortality reduction, data from a
10-year trend analysis for neonatal cause of death, coverage
and health system indicators as well as new analyses of
national and donor funding, using mainly quantitative data. A
novel statistical analysis of intervention coverage and contex-
tual factors for neonatal mortality globally and regionally is
undertaken.
Methods
Overview
The analyses used in this supplement, including this paper,
were structured according to the SNL results framework
(Figure 2) considering mortality, intervention coverage and
intermediate results and inputs, especially funding flows. We
applied standard tools for the intermediate results level to
examine policy change and events over time, as well as specific
benchmarks for newborn survival (Moran et al. 2012). We
linked quantitative data with standardized policy and
Figure 2 Saving Newborn Lives results framework
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programme assessments to unpack the process of moving to
scale for newborn survival. An overview of the input data by
level of the framework is shown in Table 1, with more details in
Supplementary Data Web Annex A.
Country selection
Different groups of countries were used for the various analyses
in this supplement and paper (Figure 3). We assessed 193
countries, all United Nations (UN) member states, for NMR
and neonatal cause of death change. The multi-country model
examining covariates of NMR reduction was developed using
144 countries, excluding those with <10 000 births per year
(32 countries) or inadequate data (17 countries). Our analysis
of donor funding was restricted to Countdown to 2015 priority
countries, which account for over 90% of newborn deaths
globally (75 countries). Then we undertook a more detailed
analysis of 18 countries in Africa, Asia and Latin America.
These countries, where SNL worked, were selected based on
criteria of burden size (number of neonatal deaths) or risk
(level of NMR), and opportunity for programmatic change at
scale. Together they accounted for 62% of neonatal deaths in
2010 and their average annual reductions in average maternal
mortality ratio (MMR), under-five mortality rate (U5MR) and
NMR were similar to the global averages.
Finally, in-depth country case studies were conducted. These
countries were selected from the 18 SNL countries by scoring
with pre-set criteria including: availability of national mortality
and coverage data; changes in NMR; changes in coverage of key
indicators, in particular skilled birth attendance; changes in
newborn health policy, programmes and research; and country
mechanism for convening national stakeholders. The five top
countries were selected (Bangladesh, Pakistan, Nepal, Malawi
and Uganda). In each of these countries, a team of national
experts was convened, including members from the Ministry of
Health, UN agencies, professional associations, academics and
non-governmental organizations (NGOs) and ranged in size
from 11 to 40 members. These teams met several times during a
two-year process, and also communicated by conference calls
and email in order to provide input data, complete standard
policy change assessments, and review and interpret changes
for newborn survival in their country.
Data sources and analysis
Neonatal mortality reduction (goal)
To analyse neonatal mortality trends, we used data from
national and sub-national household surveys, as well as from
the UN and the Institute for Health Metrics and Evaluation
(IHME) (Table 1). Descriptions of mortality estimates and the
different methods employed are given in Supplementary Data
Web Annex A. For this paper, we used UN estimates of
mortality since these provide a consistent time series, and have
been through a country review process. To assess change over
time, the average annual rate of reduction for NMR is
compared with regional rates and with changes of U5MR,
mortality of children after the neonatal period (1–59 months)
and MMR (WHO et al. 2012; UNICEF et al. 2011).
Our assessment of trends in causes of neonatal deaths
benefits from recently available time series for the years
2000–2010, using these previously published methods with
multinomial modelling to predict proportionate mortality for
193 countries (Lawn et al. 2006a; Liu et al. 2012).
Contextual factors
Political, social, economic, environmental and structural factors
are essential to consider as they may account for mortality
reduction complicating the association between direct health
interventions and observed impact (Victora et al. 2005). The
Lancet Neonatal Survival Series proposed that the level of
neonatal mortality was a tracer of health system context,
including health systems, and split countries into categories by
level of NMR for prioritizing and phasing newborn care
(Knippenberg et al. 2005). This method has also been used in
other assessments of variation across countries (Lawn et al.
2009a). We updated this analysis to examine if these NMR
groupings are useful for defining various settings and how the
situation has changed for the countries with highest and lowest
mortality over this decade.
Healthy behaviours and equitable use of effective health services
(strategic objective)
To examine change in newborn-related health interventions,
coverage data from national and sub-national household
surveys was compared over time and with regional data
(Table 1). National coverage data are primarily available for
the service delivery packages in Figure 1 (e.g. antenatal care,
skilled attendance) and for a few specific interventions that
have been a focus for longer, such as tetanus toxoid immun-
ization or breastfeeding promotion. Other high impact neonatal
interventions with recent attention, such as Kangaroo Mother
Care (Lawn et al. 2010b), have no national data available. In
order to estimate the potential impact of MNCH intervention
coverage on mortality for the five country case studies, the Lives
Saved Tool (LiST) was used (Figure 3), applying the most
recent available rates and causes of maternal, neonatal and
child deaths, by country (Box 2) (Khan et al. 2012; Mbonye
et al. 2012; Pradhan et al. 2012; Rubayet et al. 2012; Zimba et al.
2012). Supplementary Data Web Annex B provides more details
on the LiST analysis.
Evaluation of covariates of national variation in neonatal
mortality trends
To understand national variation in the annual rate of change
(ARC) of NMR, we developed a multiple linear regression
model, with national ARC of NMR between 2000 and 2010 as
the dependent variable and 13 potential covariates relating to
context and coverage. Contextual factors include gross national
income (GNI) per capita, political stability, government effect-
iveness, female literacy rate, general and adolescent fertility
rates, HIV prevalence in women aged 15–49, total health
expenditure per capita. Coverage of a range of interventions
along the continuum of care include proportion of births
attended by skilled health personnel, proportion of births
protected from tetanus (tetanus PAB), and coverage of the
third dose of diphtheria/pertussis/tetanus vaccine (DTP3) (WHO
2010). We derived annual time series, 1990–2010, of each
covariate (Supplementary Data Web Annex C1). We also
included the NMR level in year 2000 as a covariate.
For this analysis, the subsets of the covariates are highly
correlated (see Supplementary Data Web Annex C4).
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We therefore applied the elastic net algorithm to fit the
parameters in the model—this algorithm enables simultaneous
assessment of a range of covariates despite co-linearity between
contextual and coverage variables (Tibshirani 1996; Zou and
Hastie 2005). We employed the R-package ‘Glmnet’ (Friedman
et al. 2010) to use this algorithm and identify the best-
performing statistical model through 10-fold cross-validation, a
type of out-of-sample prediction error measurement (Hastie
et al. 2001). More information about the elastic net algorithm is
available in Supplementary Data Web Annex C2.
While the time period from 1990 is the MDG baseline, the
focus of this paper and supplement is the period 2000–2010
since there was minimal attention to global newborn survival
before the year 2000. In addition, 2000 was an inflection point
for rate of change for under-five mortality and to a lesser extent
neonatal mortality.
Given major regional differences in changes for mortality and
covariates, especially for sub-Saharan Africa, to minimize pos-
sible bias and to increase the predictive validity of the statistical
modelling, we fitted three separate regional multiple linear
regression models to the following MDG regional groupings: (1)
Developed region (38 countries); (2) Sub-Saharan Africa (40
countries); and (3) Other regions (66 countries).
Programme change at scale in health systems
(intermediate level)
To assess changes in national newborn policy and programmes,
a combination of qualitative and quantitative methods were
developed and applied in the country case studies (Box 3).
Progress on newborn policy and programmes was evaluated
using two standard tools: the Policy and Programme Timeline
(details available in Supplementary Data Web Annex D) and
the Scale-up Readiness Benchmarks (Moran et al. 2012).
Availability and access to newborn health services considered
health worker density, equipment and supplies for newborn
survival as well as the geographic reach of implementation
(Box 3). Quality of newborn care was examined through
assessments of health facilities, such as Service Provision
Assessments, and through specific programmes related to
quality improvement. Increased demand for newborn care
was also considered and explored though review of literature
as well as data provided in national surveys.
Financial resources for newborn health
To assess changes in funding for newborn health across
countries and in selected countries, national expenditure and
donor funding were analysed. National health funding data
were obtained from the World Health Organization’s National
Health Accounts and analysed to examine total expenditure
on health, including government, out-of-pocket and other
private expenditure (more details in Supplementary Data Web
Annex E) (WHO 2011b). Comparable data for national
spending are not systematically tracked across countries for
MNCH.
Donor health funding data were examined by reviewing
existing published estimates and by conducting an additional
Figure 3 Flowchart for country selection and analysis
Notes: a Excluding 32 countries with <10 000 annual live births and 17 countries with insufficient time series data.
b Countdown to 2015 has 75 countries. The ODA analysis excluded the Countdown to 2015 priority countries added in 2011: Comoros, Kyrgyzstan,
Solomon Islands, Sao Tome and Principe, Uzbekistan, and Vietnam. South Sudan has limited national data so was analysed with the Republic of
Sudan. The previous Countdown to 2015 MNCH funding analysis was for the 68 countries included in Countdown to 2015 at that time.
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analysis of aid benefitting newborns in the same countries and
time period. We considered data from the Organisation for
Economic Co-operation and Development (OECD)’s Creditor
Reporting System database of official development assistance
(ODA) for health 2002–2009 as well as previously published
data on ODA for MNCH between 2003 and 2008 as tracked
for Countdown to 2015 (Pitt et al. 2010), for which the
methods and limitations are detailed elsewhere (Pitt et al.
2012). In brief, a search of the Creditor Reporting System
database was undertaken for any mention of the word
‘newborn’ or a derivative, and also for 23 terms referring to
newborn-specific interventions. All projects identified were
manually reviewed and classified according to whether the
project: (1) mentions newborns, but may also benefit other
populations, or (2) exclusively benefits newborns. We present
results as total and as per capita values of ODA for health,
ODA for maternal and newborn health, and ODA for child
health (US$). All government and donor funding values are in
constant 2008 USD.
Results and discussion
Neonatal mortality reduction
Neonatal mortality declined at a slower pace than under-five
deaths in the last decade (Figure 4). Between 2000 and 2010,
the average annual rate of reduction for under-five mortality
was 2.5% (including neonatal deaths) (UNICEF et al. 2011; Hill
et al. 2012). When splitting out mortality by age of death, the
mortality for children aged 1–59 months decreased at an
average of 2.9% per year, while NMR decreased at 2.1% per
year (UNICEF et al. 2011; Hill et al. 2012). As a result, the
proportion of under-five deaths during the neonatal period
rose from 36% to more than 40%, an 11% relative increase
(Table 2a). In order to reach MDG 4, the annual rate of
reduction of under-five mortality must increase to 13.5% per
year between 2011 and 2015 globally (Figure 4); thus
accelerated reduction in neonatal mortality is increasingly
critical for progress towards MDG 4. Maternal mortality
decreased at an average annual rate of 4.2% over the decade
(WHO et al. 2012).
Box 2 Description of Lives Saved analyses used in country case studies
Background to LiST
The Lives Saved Tool (LiST) is a module in Spectrum, which is a free and widely used demographic software package
developed and refined in the past 20 years for projecting population trends by age and sex, based on UN estimates.
Embedded software models the effects of scaling up HIV interventions on HIV prevalence and mortality. The LiST models
effects on stillbirths and maternal, neonatal and child mortality as well as stunting and wasting are based on The Lancet’s
Series on Child Survival, Neonatal Survival, Maternal and Child Undernutrition and Stillbirths. LiST includes national time
series data for mortality, health status and intervention coverage. Coverage data for many interventions in low- and
middle-income countries are available through Demographic and Health Surveys (DHS), but coverage data are lacking for
many high impact neonatal interventions (e.g. rates of neonatal resuscitation), and LiST uses estimated levels for coverage
indicators based on other data, such as Service Provision Assessments (Measure DHS 2011) or national HMIS data as
described elsewhere (Johns Hopkins Bloomberg School of Public Health 2010). The detailed review process to estimate effect
sizes of cause-specific mortality, and the modelling assumptions in LiST have been published elsewhere (Boschi-Pinto et al.
2010; Stover et al. 2010; Boschi-Pinto and Black 2011).
LiST can be used to conduct both retrospective analyses and future analyses by changing coverage for selected interventions by
year and from a given baseline year. The programme links the user’s input coverage data by year to cause-specific mortality
estimates using standard effect sizes, resulting in estimates of lives saved per year by intervention and cause for a specific
country (Johns Hopkins Bloomberg School of Public Health 2010).
Country case studies
For the country case studies, a LiST retrospective analysis was used to assess mortality change from 2000 to 2010 using
coverage data from national household surveys. Since countries varied in their availability of national survey data, the
purpose of the retrospective analysis varied across country papers. For countries with nationally available data for around the
years 2000 and 2010, e.g. Bangladesh, Malawi and Nepal (Pradhan et al. 2012; Rubayet et al. 2012; Zimba et al. 2012), those
survey data points were used to determine if the mortality change predicted in LiST is consistent (within a confidence range)
with what was reported by national surveys. In the cases where national household survey mortality estimates suggest
greater mortality reduction than predicted by LiST, it may be assumed that contextual progress contributed more than
coverage increases.
LiST was also used to predict future scenarios for addressing missed opportunities in facilities for facility births, for increasing
outreach services by 20%, and for assessing potential maximum impact (90% coverage of all essential care). These analyses
used the same methods and selected interventions for scale up as Friberg et al. (2010). More details on these analyses and
input data can be found in Supplementary Data Web Annex B.
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Since 2000, China, India, Nigeria and Pakistan are among the
world’s most populous countries with the most annual births
and have consistently experienced the greatest number of
neonatal deaths (Table 2b). It is notable that Nigeria and
Pakistan now have more neonatal deaths than China, due to
China’s decreasing NMR and fertility rate. The 10 countries with
the highest numbers of neonatal deaths in 2000 (India, China,
Nigeria, Pakistan, Bangladesh, the Democratic Republic of the
Congo, Ethiopia, Indonesia, Brazil and Afghanistan) together
decreased neonatal deaths by 347 000 deaths between 2000 and
2010, contributing to 59% of the global reduction from 3.7
million to 3.1 million.
Somalia, Sierra Leone, Mali and the Democratic Republic of
the Congo have remained in the list of top five countries with
the highest neonatal mortality rates in both 2000 and 2010
(Table 2b). Two-thirds of neonatal deaths now take place in
countries with mortality above 30 deaths per 1000 live births.
All five countries in the highest mortality band (NMR 45) in
2010—Afghanistan, the Democratic Republic of the Congo,
Mali, Pakistan and Somalia—have experienced recent instabil-
ity and conflict, highlighting the gap for newborn survival
strategies in emergencies and humanitarian crises. Countries
with the least change in the risk of neonatal deaths are
primarily in sub-Saharan Africa, but some high-income
countries such as Canada, Switzerland and the United States
have also made little progress since 2000. This slower progress
may be reflective of wide availability of intensive care before
the decade started, and increasing preterm birth prevalence
in these countries during this decade (March of Dimes et al.
2012).
However, some countries have achieved remarkable progress,
with five countries more than halving neonatal mortality rates
over the decade (Turkey, Oman, Greece, Belarus and Estonia)
(Table 2c). Between 2000 and 2010, the countries in sub-
Saharan Africa with the greatest overall reduction of NMR were
Botswana and Namibia; for Southern Asia, they were Iran,
Bangladesh and Nepal. NMR was higher among the 18 SNL
countries than the global average throughout this time period,
yet varied greatly from 12 deaths per 1000 live births in
Vietnam to 48 in Mali in 2010, and the average annual rate of
NMR reduction ranged from 0.1% in Afghanistan to 4% in
Bangladesh.
Over the last decade, changes in neonatal cause of death data
and estimation methods have led to improved guidance for
policy and programmes. Until The Lancet Neonatal Series in
2005, there were no global or nationally comparable estimates
for causes of neonatal deaths. An important advance over the
past decade was the shift from ‘perinatal causes’, which include
all deaths coded in a particular chapter of the International
Classification of Diseases, to considering causes of death in the
neonatal period and using programmatically relevant grouping
(Lawn et al. 2008) (Figure 5). The previous approach hid the
high proportion of deaths in the neonatal period and also
masked the most easily preventable causes of neonatal deaths—
tetanus and infections—by including them in the ‘Other’
grouping. Co-ordinated by the Child Health Epidemiology
Box 3 Methods to assess changes in national newborn policies, programmes and processes
To assess changes in national newborn survival policy and programmes, mixed qualitative and quantitative methods were
developed and applied. Data were collected through review of national reports, assessments, guidelines, newborn situation
analyses and programme documents, and were then reviewed by key national stakeholders. The standard tools applied
include the following:
Policy and Programme Timeline
Tool: A standardized format and protocol for historical review of critical events and changes for policies, programmes,
advocacy and research at country level to identify pivotal events that may have influenced the national newborn health
landscape positively or negatively (Supplementary Data Web Annex D).
Protocol: For each country, events relating to newborn survival were recorded from 2000 to 2010 at three levels: the national
context; national level health policies, strategies and plans showing incorporation of MNCH; and newborn-specific
programmes and activities, e.g. activities to reduce deaths due to preterm complications, intrapartum-related deaths and
infections. National expert groups completed the timeline, which was then critically reviewed by other stakeholders
in-country (8–40 experts), including an exercise to select the most influential events for newborn survival in the last decade.
Scale-up Readiness Benchmarks
Tool: A scoring of 27 selected markers for scale up readiness for newborn health that address themes around agenda-setting,
policy formulation and implementation (Moran et al. 2012).
Protocol: Experts in each of the selected countries completed a checklist of benchmarks each categorized as achieved, partially
achieved, or not achieved for three time points (2000, 2005, 2010). The results from the benchmark tool were compared with
the policy and programme timeline and supporting policy and programme documents for consistency (Moran et al. 2012).
Geographic reach of implementation
We worked with in-country teams to assess and document the geographic reach of selected packages of care relevant to
newborn survival using information collected from Ministries of Health, UN agencies, Save the Children and other
implementing partners. The reach was shown by district on national maps, where possible giving the ratio of trained staff per
capita of total population.
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Reference Group (CHERG), consensus was reached on a short
list of programmatically-relevant causes of neonatal death that
could be distinguished in verbal autopsy data and mapped onto
the International Classification of Disease codes (Lawn et al.
2006a). Using data inputs from vital registration and various
studies, a multinomial model was developed to estimate
proportionate mortality within the neonatal period for 193
countries (Lawn et al. 2005; Lawn et al. 2006a). This method is
now used for annual updates by CHERG and the World Health
Organization (WHO) (Liu et al. 2012).
Three causes of death account for more than 85% of the
world’s 3.1 million neonatal deaths: complications of preterm
birth, infections and intrapartum-related causes (‘birth as-
phyxia’). Across regions, the NMR level and rate of reduction
varies, but cause-specific mortality changes are less marked
(Figure 6). When arranged by NMR level, countries in the two
highest mortality bands have higher proportions of infections
and deaths from intrapartum-related causes than countries
with the lowest overall mortality (Lawn et al. 2009a).
There has been impressive progress in reducing deaths from
neonatal tetanus with a 92% decrease since the late 1980s
(Roper et al. 2007; Blencowe et al. 2010). Despite two global
elimination target dates in the past decade, maternal and
neonatal tetanus has not yet been eliminated, with approxi-
mately 60 000 newborns dying each year from tetanus (Liu et al.
2012), primarily in a limited number of large countries with
insufficient rates of tetanus toxoid immunization and low
coverage of facility births, such as Nigeria and India (Blencowe
et al. 2010). Some progress has been made in reducing deaths
from other neonatal infections, especially pneumonia and
diarrhoea, and some progress for intrapartum-related neonatal
causes (Lawn et al. 2010a; Liu et al. 2012). Neonatal deaths
globally are dominated by complications of preterm birth as a
direct (35%) and also indirect cause of deaths, such as death
from infection in complications of moderately preterm babies
(March of Dimes et al. 2012). Historical trends in high-income
countries also show an increasing proportion of neonatal deaths
due to preterm complications, but the gestation-specific risk has
been dramatically changed by neonatal intensive care (March
of Dimes et al. 2012).
Changes in context
Table 3 shows 193 countries organized into five categories
according to their level of NMR in 2010 and the associated
variation of contextual factors and health system markers
(Knippenberg et al. 2005; Lawn et al. 2009a). The median GNI per
capita in the 50 countries with NMR 5 is 40 times more than the
five countries with NMR 45 (US$33 990 and US$847, respect-
ively. Rate change of GNI between 2000 and 2010 had minimal
variation across the categories. Female literacy was considerably
lower for high mortality settings (49% in Category 4 and 29%
in Category 5), compared with 96% in Category 1 with NMR <5.
Other contextual variables such as urbanization, cell phone use
and food security may have important associations with health
outcomes but are not shown here.
Progress for coverage of newborn survival interven-
tions and health system performance
These NMR categories also help delineate the variation of
health system settings, especially at the time of birth. Skilled
birth attendant coverage is universal in the low mortality
countries but less than 50% in high mortality settings (Table 3).
Figure 4 Progress towards Millennium Development Goal 4 for child survival showing progress globally (193 countries)
Data sources: UN Interagency Group for Child Mortality Estimates (UNICEF et al. 2011) with new analysis of mortality trend by age at death.
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The median caesarean delivery rate ranges from 24% in
Category 1 to 2.6% in Category 4 and 5 countries. Though
high caesarean section rates are not desired, rates less than 5%
are a marker of lack of availability of emergency and neonatal
intensive care, especially in rural areas. Health worker density
varies markedly across NMR categories. The density of mid-
wives and nurses is over 30-fold higher in Category 1 (664 per
10 000 population) compared with Category 4 (57 per 10 000
population) and Category 5 (30 per 10 000), and the density of
doctors is 50 times higher.
Changes in coverage levels of newborn-related interventions
differ by region and indicator. In the past two decades, there
has been little change in the coverage of skilled birth attend-
ance (an indicator for MDG 5) in sub-Saharan Africa and South
Asia, where more than two-thirds of maternal and neonatal
deaths occur (Lawn et al. 2009b). Yet recent data from several
sub-Saharan African and South Asian countries show a rapid
change in coverage. In some cases, incentives may have played
a key role (Lim et al. 2010; Basinga et al. 2011), but in others,
such as Malawi, there were many changes at the same time,
with community mobilization and redefining roles for trad-
itional birth attendants, as well as facility refurbishment
(Zimba et al. 2012).
Additionally, exclusive breastfeeding has increased in most
regions (UNICEF 2011). Challenges remain in definition
variation of ‘exclusive’ between various survey tools.
Descriptive data analyses suggest that immediate breastfeeding
is associated with reduced neonatal mortality, while attempting
control for reverse causality (Edmond et al. 2006). Globally, less
than half of newborns are breastfed within 1 hour of birth
(UNICEF 2011).
Predictors of neonatal mortality reduction
The three regional multiple linear regression models—for
Developed Region, Sub-Saharan Africa and Other Regions—
identify the relative importance of covariates of NMR reduction
from 2000 to 2010 (Figure 7). Between 2000 and 2010, the
Table 2 Changes for maternal, newborn and child survival 2000–2010 (193 countries)
a. Births and deaths
2000 2010
Live births 131 140 000 134 683 000
Maternal deaths 451 000 359 000
Stillbirths 2 850 000 2 650 000*
Under-five deaths 10 169 000 7 614 000
Neonatal deaths 3 681 000 3 072 000
Neonatal deaths as %
of under-five deaths
36% 40%
b. Country ranking by neonatal mortality rates and by numbers of neonatal deaths
Highest neonatal mortality Highest number of newborn deaths
2000 2010 2000 2010
Sierra Leone (53) Somalia (52) India India
Mali (52) Mali (48) China Nigeria
Somalia (52) DR Congo (46) Nigeria Pakistan
DR Congo (48) Sierra Leone (46) Pakistan China
Angola (47) Afghanistan (45) Bangladesh DR Congo
Nigeria (46) Central African Republic (43) DR Congo Ethiopia
Burundi (46) Burundi (42) Ethiopia Bangladesh
Mozambique (45) Angola (41) Indonesia Indonesia
Liberia (45) Pakistan (41) Brazil Afghanistan
Pakistan (45) Chad (41) Afghanistan Sudan
c. Countries with the largest neonatal mortality rate reduction from 2000 to 2010 (% change)
Developed region Sub-Saharan Africa Other regions (Asia, North Africa and Latin America)
Estonia (58%) Botswana (38%) Oman (53%)
Belarus (55%) Namibia (35%) Turkey (51%)
Greece (55%) Rwanda (32%) El Salvador (46%)
Slovenia (48%) Malawi (29%) Peru (45%)
Ireland (47%) Tanzania (28%) Egypt (45%)
* For 2009.
Data sources: Neonatal deaths, under-five deaths and live births from UN (UNICEF et al. 2011). Trends in maternal mortality from WHO et al. 2012. Stillbirth
from Cousens et al. (2011). Note: Excluding countries with <10 000 annual live births.
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NMR decreased in each of the 144 countries included (Figure
3), meaning that the ARC of NMR was negative for these
countries over this period. Supplementary Data Web Annex C3
shows the high co-linearity between covariates and the asso-
ciation between ARC of NMR and each of the covariates for
each of the models in the form of two-way Pearson correlation
matrices (see Supplementary Data Web Annex C for more
details).
For developed countries, NMR reduction occurred more
rapidly than for other regions, at over 3.0% per year. Many
covariates showed an association with NMR reduction, but the
two covariates explaining the most variation in ARC of NMR
(2000–2010) were ARC of GNI per capita and of the general
fertility rate. ARC of GNI per capita is strongly correlated with
ARC of total health expenditure across these countries (see
Supplementary Data Web Annex C3), which suggests that for
most of these countries economic development has translated
into relative increases in national health expenditure (see
Supplementary Data Web Annex C4). In this group of
countries, Balkan and Eastern European countries have seen
the largest proportionate reduction in NMR and have made
rapid recent improvements in neonatal intensive care. A critical
agenda in these countries is more focus on impairment
outcomes (Mwaniki et al. 2012).
Figure 5 Global estimates for causes of death for neonates and children 2000 and 2010. Note: The purpose of these figures is to show change in
methodology of cause of death in 2000 and 2010; therefore the data in these figures cannot be compared since data collection methods varied.
(a) Child and neonatal causes of death globally in 2000: neonatal deaths comprised 36% of under-five deaths but were not visible, being split across
‘perinatal causes’ and other categories. Source: United Nations estimates (Lawn 2009). Note: Estimates were used until early 2005, including by WHO
and UNICEF and as the basis for integrated management of childhood illnesses (IMCI). (b) Child and neonatal causes of death global estimates for
193 countries for the year 2010: increased visibility for deaths in the neonatal period as well as increased programme relevance and increased quality
of all the input data and national estimation methods. Source: CHERG and WHO (Liu et al. 2012).
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For sub-Saharan African countries, the average rate of
reduction of NMR has been very low at around 1% per year,
and thus statistical covariates of change are more difficult to
detect (Figure 7). High NMRs in the year 2000 were associated
with slower progress, presumably since most of the countries
that had not previously managed to reduce NMR continued to
make little progress. The single strongest covariate of ARC of
NMR, after baseline NMR, is ARC of tetanus protected at birth
(tetanus PAB). An increase in tetanus PAB was weakly
associated with slower NMR reduction, but this may be because
countries with very low baseline tetanus PAB coverage and
rapid increases in coverage were those with the weakest health
systems, which often faced other challenges, for example
Nigeria and Ethiopia. Since 2000, 14 countries achieved
maternal neonatal tetanus elimination and most of these
were countries with stronger health systems (WHO 2012).
While neonatal tetanus reduction is feasible and important,
tetanus accounts for fewer than 2% of neonatal deaths globally
and this intervention alone will not result in dramatic NMR
reduction going forward.
For other countries included in the model, mainly in Asia and
Latin America, there has been variable NMR change, with
outlying countries experiencing rapid progress (e.g.
Bangladesh) or slower progress (e.g. Pakistan). The three
covariates explaining most of the variation in ARC of NMR
for these countries were ARC of general fertility rate, ARC of
skilled birth attendance and baseline NMR in 2000. Oman,
Turkey, United Arab Emirates, Egypt, El Salvador and Peru had
large relative reductions in NMR and general fertility rate
(Supplementary Data Web Annex C4). Reductions in total
fertility likely contributed to MMR reduction as well as NMR,
as shown in Nepal and Bangladesh (Pradhan et al. 2012;
Rubayet et al. 2012). The marginally negative association with
skilled birth attendance may be related to the dominance of
countries in this regional group that had constant universal
skilled birth attendance throughout the decade, e.g. South
Korea, Colombia and the Philippines, hence limiting statistical
associations.
Financial resources for newborn health
On average for the Countdown to 2015 priority countries, total
health expenditure more than tripled since 2000 (Figure 8a)
(WHO 2011b). Average per capita total health expenditure
increased from $40 to $108, which is above the Commission on
Macroeconomics and Health’s suggested minimum $34 per
capita annual expenditure needed for an essential package of
health interventions ($53 at constant 2008 USD) (WHO 2001).
In 2000, 50% of total health expenditure was from direct costs
to families but this decreased to 41% in 2010 (WHO 2011b;
Hercot et al. 2011). Average government spending on health
was 9% of overall government expenditure, much lower than
the Abuja target of 15% (Figure 8a) (WHO 2011b).
Donor contributions for health increased. Between 2003 and
2008, ODA for MNCH more than doubled, although some
countries experienced significant fluctuations (Pitt et al. 2010).
ODA for child health received the majority of the value of
disbursements to MNCH (Figure 8b). Before 2005, newborns
were rarely mentioned in donor disbursements, but from 2003
to 2008, the value of donor disbursements to the 68 Countdown
priority countries mentioning newborns increased from $25.0m
to $233.7m (constant 2008 USD). Yet by 2008, the most recent
year for which MNCH estimates are available, only 6.1% of the
value of MNCH ODA to the Countdown countries even
mentioned newborns (Pitt et al. 2012), despite neonatal
deaths accounting for more than one-third of all maternal
and child deaths. Of all the funding related to newborn care
from 2002–2009, the USA contributed a total of $619.5m,
almost four times the next country, Canada, at $163.9m. The
top five recipient countries for aid containing any mention of
newborns are Bangladesh ($283.3m), Tanzania ($96.9m),
Pakistan ($95.5m), Afghanistan ($82.9m) and India ($81.9m).
Four of these five countries are in South Asia, where over half
Figure 6 Cause-specific neonatal mortality rates by WHO regions from 2000 to 2010. Data sources: Analysis from CHERG/WHO neonatal cause of
death time series (Liu et al. 2012). Note: Infections include sepsis, pneumonia, diarrhoea and tetanus.
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of under-five deaths take place in the neonatal period, but
given their large populations, the value per birth is still very
low. The amount of non-research ODA exclusively targeted at
newborns in the priority countries was extremely low at $5.49m
in 2009, but if newborn research funding, all of which was
provided by the Bill & Melinda Gates Foundation in 2009, is
included, this increases to $55.93 million (Pitt et al. 2012).
Implications
This is the first multi-country analysis of neonatal mortality
reduction, highlighting global progress since 2000, while con-
sidering variation between regions and countries. Newborn
survival interventions can be integrated with those for mothers
and for children after the newborn period, but have received
limited attention until very recently (Shiffman 2010). Since
1990, mortality rates during the first month of life (NMR) have
declined at a slower pace compared with maternal deaths and
deaths in children aged 1–59 months. Since 2000, NMR
reduction globally has accelerated by 40%, compared with the
1990s (Hill et al. 2012), but still lags behind maternal and
under-five survival gains. The rich–poor survival gap continues
to widen as high-income countries have continued to reduce
NMR rapidly at an average of 3% per year since 2000. However,
in sub-Saharan Africa, the poorest region, the rate of reduction
is still extremely slow despite slight improvement (1.5% from
2000 to 2010 compared with 0.6% from 1990 to 2000). Unless
further accelerated, it will be over 150 years before African
babies have the same chance of survival as those born in
high-income countries (Oestergaard et al. 2011). Some
low-income countries, such as Bangladesh, Nepal and
Rwanda, have made dramatic progress in reducing the NMR
by more than 30% in the last decade.
Our analysis here and the country case studies elsewhere in
this supplement provide insights on the variation in progress
achieved and underline priorities for improving data for future
programme monitoring evaluation. The standard framework,
tools and analyses used by an inclusive national review group
to assess change in countries may be adapted for analysing
progress in scaling up care for other health priorities, particu-
larly those which involve service delivery packages and wider
demand and supply system changes.
Understanding NMR change
The new cause of death trend analysis for the decade (Liu et al.
2012) gives useful insights on which causes, and potentially
which linked programmes, have made most progress. The
reduction in neonatal tetanus is most obvious with an average
annual rate of reduction at a dramatic 9.5% per year (Liu et al.
2012). Neonatal infections that can be reduced through child
health programmes are reducing noticeably. For example,
diarrheoa reduced on average 4% per year and pneumonia
reduced 2.2% per year. Neonatal sepsis shows less progress.
Intrapartum-related neonatal deaths reduced at 2.4% per year,
perhaps as a ‘trickle down’ from maternal health care invest-
ment as obstetric care has the highest impact on this cause.
Additional benefit would be expected from systematically
ensuring that neonatal resuscitation is available for all babiesT
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who do not breathe at birth. Deaths due to preterm birth
complications reduced at 2% per year (Liu et al. 2012) and
addressing these deaths requires specific skills, such as for
feeding support and Kangaroo Mother Care, and at least some
basic commodities. Indeed, it was the care of preterm babies
that prompted the development of neonatology in high-income
countries. Based on a Lives Saved Tool (LiST) analysis, major
mortality reduction could be achieved before adding neonatal
intensive care through high coverage (95%) of antenatal
corticosteroids (almost 400 000 lives saved in 2015) and
Kangaroo Mother Care (450 000 lives saved in 2015) (March
of Dimes et al. 2012). Over the last decade, the main message
for global newborn care has been to integrate within existing
service delivery packages (Figure 1). However, to accelerate
progress for preterm deaths, there is an urgent need to transit
to more specialized newborn care, particularly in countries
where the NMR is reducing towards 15 per 1000, the mortality
level when neonatal intensive care came into play in
high-income countries (March of Dimes et al. 2012).
Our three regional multiple linear regression models suggest
that the last decade’s reduction in NMR globally has differed by
region. For all three regional models, the progress in reducing
NMR seen in the last decade is associated with a country’s
NMR level at baseline. The Lancet Neonatal Series used NMR
level to categorize countries, and the analysis presented in this
paper (Table 3), with more data and countries, supports the
value of using baseline NMR as a guide for prioritizing and
phasing newborn care interventions. However, the association
of NMR level and countries’ progress for neonatal survival over
time manifests differently around the world. For high-income
countries, a relatively high NMR in 2000 allowed scope for
rapid change, which in many cases was realised. For
low-income countries, a high NMR in 2000 was associated
with least change, especially in sub-Saharan Africa. Those
countries with the highest NMRs may have challenges outside
and/or within the health system and are also likely to have
limited focus on scale up of neonatal survival interventions in
these contexts. In Asia, Latin America and the Middle East,
fertility reduction was more strongly associated with rapid
NMR reduction.
The limited coverage data available were not strongly predictive
in the model and indeed did not change much over the decade.
Skilled attendance alone, as it is currently defined, is poorly
predictive and this may be because saving lives, especially of
babies who can die within minutes, depends on providers being
equipped, skilled and supported, instead of merely present at
birth. The main implication is that the progress to date for NMR
reduction across all these countries cannot currently be attributed
to a major increase in scale up of a key package, such as postnatal
care, or a complex intervention, such as neonatal resuscitation.
From the limited countries with some coverage or process data
(most of which had more attention for newborn survival), we
know these interventions are only starting to be scaled up (Khan
et al. 2012; Mbonye et al. 2012; Pradhan et al. 2012; Rubayet et al.
2012; Zimba et al. 2012).
Tracking financial resources for newborn pro-
grammes in countries
Donor resources for MNCH have increased dramatically over
the last decade, but there is no standard, national level
information on government resources specifically for MNCH,
let alone newborns. Donor funds are not the main recurrent
inputs for health expenditure in most countries. Annual
assessment of reproductive and MNCH government funding
has been recommended as a measure of accountability (Hsu
et al. 2011).
Despite a doubling of ODA for MNCH between 2003 and 2008
and increasing relative attention to newborns within funding
Figure 7 Ranking of predictors for their influence on ARC of NMR in the period 2000–2010, and estimated regression coefficients in the multiple
linear regression model. Note: Empty cells indicate no influence when accounting for other predictors. Of the included predictors in each model fit,
relative influence of each predictor on ARC of NMR 2000–2010 is indicated in parenthesis with most important predictor as (1). The estimated
coefficients for the intercept in each of the models were: 0.027 for developed regions; 0.018 for sub-Saharan Africa; and 0.032 for other
countries. Ranking of predictors is based on fitting the multiple linear regression model net model to standardized predictors. Estimated coefficients
are from modelling on original scale of predictors. As the original scale varies between predictors one cannot assess relative influence from the value
of the estimated coefficients. A positive regression coefficient for a predictor indicates that countries with larger positive values of the predictor
tended to have experienced slower declines in NMR over the period. In contrast, a negative regression coefficient means that countries with large
negative values of the predictor were more likely to experience a faster decline. ARC: annual rate of change. Millennium Development Goal regions
available from http://mdgs.un.org/unsd/mdg/Host.aspx?Content=Data/RegionalGroupings.
*The group ‘‘other regions’’ includes from North Africa, Asia and Latin America and Caucasus and Central Asia.
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descriptions, activities that benefit newborns specifically were
only mentioned in a small fraction of donor funding for MNCH,
and funding for newborns came from a very limited number of
donors. USAID contributed the largest amount of funding that
mentioned newborns, which was double the value of the next
largest donor, The World Bank. A limitation of any analysis of
the OECD databases is the varying quality of description of
disbursements, which may result in the data not fully reflecting
Figure 8 Changes in financial resources related to newborn survival, 2000–2009
(a) Average total health expenditure in Countdown priority countries 2000–2009 by government, out-of-pocket, and other private expenditure,
(constant 2008 USD). Data source: World Health Organization National Health Accounts. Note: 69 countries included. Out of 75 Countdown priority
countries the following countries were excluded due to missing data: Afghanistan, DPR Korea, Liberia, Somalia and Zimbabwe. South Sudan data
included with Sudan. (b) Changes in newborn-related official development assistance (ODA) for maternal, newborn and child health (MNCH) for
68 Countdown to 2015 priority countries, 2003–2008 (constant 2008 USD) Data source: Data from Pitt et al. (2012). Note: Countdown to 2015 priority
countries included with exception of countries added in 2011: Comoros, Kyrgyzstan, Solomon Islands, Sao Tome and Principe, Uzbekistan and
Vietnam. South Sudan data included with Sudan.
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the content of all donor programmes. Tracking of
newborn-related and newborn-specific donor funding is feas-
ible, and we believe is a useful quantitative marker of
accountability (Pitt et al. 2012). Tracking government funding
for MNCH is at least as important and remains a gap.
Considerably more investment and effort is required to
accelerate scale up of evidence-based newborn care, to adjust
interventions and packages to account for context, and to
support the development of strong primary health care infra-
structure, such as supported and trained community-level
workers linked with functioning primary and referral level
facilities. Engagement with the private sector or alternative
financing models has received limited systematic attention to
date.
Limitations in the data and analyses
This retrospective analysis aiming to understand progress across
regions and countries for newborn survival faced the major
challenge of limited national data, particularly most newborn
survival interventions. For example, data are available for
postnatal care for women in 22 countries, but only four
countries report postnatal care for the baby with all-births as
the denominator (Requejo et al. 2012). Coverage data on
Kangaroo Mother Care are not routinely collected in household
and facility-based surveys, or even routine health information
systems. Some interventions that save the lives of mothers and
children are also those that will impact newborn survival (e.g.
skilled attendance at birth, breastfeeding) and more of those
interventions have national trend data. However, some covari-
ates of interest, such as caesarean section rates, have limited
time series data for all countries and cannot be examined as
covariates. Even where data exist, they may not always be
disaggregated to reveal the care accessed by the poorest or most
vulnerable populations, or by gender.
Our analysis of inter-country covariates of NMR reduction
does not identify causal relationships between covariates and
NMR trends; instead it seeks to understand the predictors of
variation between countries’ NMR reduction. Rigorous evalu-
ation of change at scale in varying contexts is a high priority.
Changes over the last decade for newborn
survival data
One of the key reasons for increasing attention to newborn
survival has been the increased visibility arising from improved
data, its interpretation for policy and programmes and the
linkage with MDG 4, and also now with the UN’s Every Woman
Every Child strategy (Ban 2010). Before 2005, there were no
regular NMR estimates, no published detailed methodology and
NMR was not shown in key UN reports. Now there are credible
estimates, inclusion in annual UN reports (Bryce and Requejo
2010; UNICEF 2011; WHO 2011c; Requejo et al. 2012) and time
series for NMR (Oestergaard et al. 2011), and for early NMR
(Lozano et al. 2011). In addition, stillbirth rates are now also
reported (Cousens et al. 2011) (Table 1).
Programmatically relevant and technically credible cause of
death estimates were a critical step in attention for millions of
neonatal deaths and linking causes to programmatic solutions
(Figure 5). Important gaps remain for counting deaths,
improving vital statistics and cause of death data (Setel et al.
2007). While improvements in global, regional and national
level estimation methods are welcome, better real-time data
that can be used for decision making and programme planning
is a long-term goal (The PLoS Medicine Editors 2010).
Approaches to use data for action have been helpful; examples
include the cause of death figures on the Countdown to 2015
profiles (Requejo et al. 2012) and national and sub-national
situation analyses (Ministry of Health 2008; Federal Ministry of
Health 2011; Manji 2009).
Coverage, quality and equity information gaps are especially
critical in planning and tracking services. Inter-agency efforts
are underway to improve measurement of intervention coverage
and behaviours and will be addressed through large-scale
surveys and national health information systems. Measurement
improvements for the quality and availability of newborn care
interventions have been improved, such as adding questions in
facility assessment tools on the availability and quality of
newborn-specific services and commodities, and assessing
existing services against agreed standards for newborn care
(Measure DHS 2011; Mbonye et al. 2012). Tracking policy
change and benchmarks with wide country consensus are
critical for advancing newborn survival on national agendas.
However, as long as feedback mechanisms, such as improved
tracking of coverage data, do not exist to raise the profile or
maintain attention for newborns along with their mothers,
progress to establish enabling policies and deliver programmes
to address the causes of their deaths will continue to be
tenuous (Shiffman 2010).
Conclusion
Given the relatively recent attention for neonatal survival, and
the limited investment in countries with the highest numbers of
deaths, it is not surprising that progress for reducing neonatal
deaths is slower than for mortality amongst children aged 1–59
months and for maternal mortality. Inputs, including donor
funding, have increased since 2005, but are not commensurate
with the burden. Preterm birth is increasingly dominant as both
a direct and an indirect cause of death and now the second
leading cause of under-five child deaths. The global public health
community urgently needs to respond to this challenge. Research
in several regions has shown encouraging results through both
community and facility-based initiatives.
Improvements in frequency and visibility of estimates for
neonatal mortality and causes of death may have helped gain
attention. Data gaps for morbidity, coverage of care and quality
of services remain critical constraints to planning programmes
and tracking progress, and to the wider economic benefits and
effects of newborn survival. However, data improvements alone
do not save lives—health system and coverage change are
crucial. Findings from this supplement, particularly the country
case studies, have the potential to inform context-specific,
accelerated progress for newborn survival (Khan et al. 2012;
Mbonye et al. 2012; Pradhan et al. 2012; Rubayet et al. 2012;
Zimba et al. 2012).
The rapid progress for some countries shows that NMR can be
halved within a decade. The countries with the most progress
include mainly high- and middle-income countries; yet there
are a few notable low-income country exceptions, such as
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Bangladesh (Rubayet et al. 2012) and Nepal (Pradhan et al.
2012) that have both reduced by double the global average.
Increased global and national attention to effective scale up of
neonatal care in the highest burden countries would save many
lives. Without major increased focus on the implementation of
high impact newborn care, linked to MNCH programmes and
investments, newborn mortality will be the most significant
child survival challenge after the MDG target data in 2015 and
the survival gap between babies born in the richest and the
poorest countries will continue to increase.
Supplementary Data
Supplementary data are available at Health Policy and Planning
Online.
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